These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

255 related articles for article (PubMed ID: 26094984)

  • 1. Silencing of Livin inhibits tumorigenesis and metastasis via VEGF and MMPs pathway in lung cancer.
    Lin X; Li HR; Lin XF; Yu ME; Tu XW; Hua ZD; Lin M; Xu NL; Han LL; Chen YS
    Int J Oncol; 2015 Aug; 47(2):657-67. PubMed ID: 26094984
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Effects of human Livin gene down-regulation by RNA interference on xenograft of transplantation tumor induced by SPC-A1 in nude mice].
    Chen YS; Li YT; Li HR; Chen XY; Lin LF
    Zhonghua Jie He He Hu Xi Za Zhi; 2011 Jan; 34(1):43-7. PubMed ID: 21429419
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Local injection of lentivirus-delivered livinshRNA suppresses lung adenocarcinoma growth by inducing a G0/G1 phase cell cycle arrest.
    Chen YS; Li HR; Miao Y; Chen WY; Li YT; Wang GQ; Wu ZC
    Int J Clin Exp Pathol; 2012; 5(8):796-805. PubMed ID: 23071862
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Transfection with Livin and Survivin shRNA inhibits the growth and proliferation of non‑small cell lung cancer cells.
    Huang Q; Zeng Y; Lin H; Zhang H; Yang D
    Mol Med Rep; 2017 Nov; 16(5):7086-7091. PubMed ID: 28901499
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Knockdown of Livin inhibits growth and invasion of gastric cancer cells through blockade of the MAPK pathway in vitro and in vivo.
    Ou JM; Ye B; Qiu MK; Dai YX; Dong Q; Shen J; Dong P; Wang XF; Liu YB; Quan ZW; Fei ZW
    Int J Oncol; 2014 Jan; 44(1):276-84. PubMed ID: 24220265
    [TBL] [Abstract][Full Text] [Related]  

  • 6. siRNA targeting Livin decreases tumor in a xenograft model for colon cancer.
    Oh BY; Lee RA; Kim KH
    World J Gastroenterol; 2011 May; 17(20):2563-71. PubMed ID: 21633662
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Silencing Livin induces apoptotic and autophagic cell death, increasing chemotherapeutic sensitivity to cisplatin of renal carcinoma cells.
    Wang Z; Liu S; Ding K; Ding S; Li C; Lu J; Gao D; Zhang T; Bi D
    Tumour Biol; 2016 Nov; 37(11):15133-15143. PubMed ID: 27677286
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inhibition of livin expression suppresses cell proliferation and enhances chemosensitivity to cisplatin in human lung adenocarcinoma cells.
    Zhuang L; Shen LD; Li K; Yang RX; Zhang QY; Chen Y; Gao CL; Dong C; Bi Q; Tao JN; Wang XN; Tian Q
    Mol Med Rep; 2015 Jul; 12(1):547-52. PubMed ID: 25695324
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Role of inhibitor of apoptosis protein Livin in radiation resistance in nonsmall cell lung cancer.
    Sun JG; Liao RX; Zhang SX; Duan YZ; Zhuo WL; Wang XX; Wang ZX; Li DZ; Chen ZT
    Cancer Biother Radiopharm; 2011 Oct; 26(5):585-92. PubMed ID: 21883015
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Livin mediates tumor cell invasion in the DU-145 cell line via NF-κB.
    Chen F; Yang D; Che X; Wang J; Li X; Zhang Z; Chen X; Song X
    Oncol Rep; 2012 Jun; 27(6):2010-6. PubMed ID: 22427141
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Livin promotes progression of breast cancer through induction of epithelial-mesenchymal transition and activation of AKT signaling.
    Li F; Yin X; Luo X; Li HY; Su X; Wang XY; Chen L; Zheng K; Ren GS
    Cell Signal; 2013 Jun; 25(6):1413-22. PubMed ID: 23524337
    [TBL] [Abstract][Full Text] [Related]  

  • 12. RNA interference-mediated knockdown of Livin suppresses cell proliferation and invasion and enhances the chemosensitivity to cisplatin in human osteosarcoma cells.
    Li X; Fan S; Li L; Wang L; Fan G; Zhao Q; Li Y
    Int J Oncol; 2013 Jul; 43(1):159-68. PubMed ID: 23632777
    [TBL] [Abstract][Full Text] [Related]  

  • 13. miR-198-induced upregulation of Livin may be associated with the prognosis and contribute to the oncogenesis of lung adenocarcinoma.
    Liang Y; Wang H; Sun Y; Chen S; Wang H; Huang R; Zhao X; Fu W; Yang C
    Oncol Rep; 2017 Oct; 38(4):2096-2104. PubMed ID: 28765921
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Silencing Livin gene expression to inhibit proliferation and enhance chemosensitivity in tumor cells.
    Wang R; Lin F; Wang X; Gao P; Dong K; Zou AM; Cheng SY; Wei SH; Zhang HZ
    Cancer Gene Ther; 2008 Jun; 15(6):402-12. PubMed ID: 18340356
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Expression and role of the inhibitor of apoptosis protein livin in chemotherapy sensitivity of ovarian carcinoma.
    Liu X; Wang A; Gao H; Yuan Z; Jiao Y
    Int J Oncol; 2012 Sep; 41(3):1021-8. PubMed ID: 22766624
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Expression of livin in gastric cancer and induction of apoptosis in SGC-7901 cells by shRNA-mediated silencing of livin gene.
    Wang TS; Ding QQ; Guo RH; Shen H; Sun J; Lu KH; You SH; Ge HM; Shu YQ; Liu P
    Biomed Pharmacother; 2010 May; 64(5):333-8. PubMed ID: 19914791
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Expression of livin in gastric cancer and effect of silencing of the livin gene on apoptosis in gastric cancer cells].
    Liu P; Wang TS; You SH; Ge HM
    Zhonghua Zhong Liu Za Zhi; 2007 Aug; 29(8):570-4. PubMed ID: 18210873
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Expression of Livin and the inhibition of tumor progression by Livin silencing in laryngohypopharyngeal cancer.
    Yoon TM; Kim SA; Lee DH; Lee JK; Park YL; Lee KH; Chung IJ; Joo YE; Lim SC
    In Vivo; 2014; 28(5):751-9. PubMed ID: 25189886
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Livin contributes to tumor hypoxia-induced resistance to cytotoxic therapies in glioblastoma multiforme.
    Hsieh CH; Lin YJ; Wu CP; Lee HT; Shyu WC; Wang CC
    Clin Cancer Res; 2015 Jan; 21(2):460-70. PubMed ID: 25370472
    [TBL] [Abstract][Full Text] [Related]  

  • 20. CYLD downregulates Livin and synergistically improves gemcitabine chemosensitivity and decreases migratory/invasive potential in bladder cancer: the effect is autophagy-associated.
    Yin L; Liu S; Li C; Ding S; Bi D; Niu Z; Han L; Li W; Gao D; Liu Z; Lu J
    Tumour Biol; 2016 Sep; 37(9):12731-12742. PubMed ID: 27448305
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.